🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
Phase 3 study to evaluate the extended safety of RVL-1201 compared to place...
Status
Completed
Location
Barnet, Dulany Perkins
Start Date
2018-06-20
Trial ID
NCT03536949
Treatments Being Tested
The purpose of this Phase 1b study is to evaluate the safety, tolerability,...
Status
Completed
Location
PPD
Start Date
2019-05-02
Trial ID
NCT04284514
Treatments Being Tested
This study will examine the safety, tolerability and efficacy of NVXT in a ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02343627
Treatments Being Tested
The purpose of this study was to describe the safety and IOP-lowering effic...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00670033
The purpose of this study is to evaluate the safety and intraocular pressur...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00761709
Treatments Being Tested
The objectives of this study are to evaluate the safety and analgesic effic...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02081703